Medicines Australia and the Generic and Biosimilar Medicines Association have recommended some policy adjustments in their joint submission to the Minimum Stockholding Requirements 12-month Review.
Joint submission recommends adjustments to minimum stockholding requirement
June 24, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Neuren’s first dividend signals a new phase built on DAYBUE royalties
August 26, 2026 - - Australian Biotech -
Starpharma narrows loss as Genentech deal lifts revenue and new funding extends runway
August 26, 2026 - - Australian Biotech -
Genetic Signatures and Microba explore merger to build infectious disease diagnostics group
August 26, 2026 - - Australian Biotech -
Australian company secures European approval for rare disease treatment
August 26, 2026 - - Latest News -
Australia cannot deliver meaningful change until the levers of power are rebalanced
August 26, 2026 - - Latest News -
Professor Brandon Wainwright appointed to lead QIMR Berghofer
August 25, 2026 - - Latest News -
Insurers warn cut could hit Australians most likely to need cancer care
August 25, 2026 - - Latest News

